In contrast, non-IG rearrangements of FOXP1 are found as secondary genetic hits acquired during clinical course of various B-cell neoplasms (DLBCL, MZL and CLL), frequently heralding inferior outcome. The gene discussed is FOXP1; the disease is B-cell chronic lymphocytic leukemia.